Advertisement

`

Microneutralization Assay for Swine Influenza Virus in Swine Serum

Authors:

Abstract

The microneutralization (MN) assay is a modification of the serum virus neutralization assay and is a serological test to detect the presence of functional systemic antibodies that prevent infectivity of virus. When infectious virus is mixed with serum antibody, the virus infectivity can be “neutralized” if the antibodies bind to blocking epitopes on the virus. The neutralization effect can be demonstrated by inoculation of susceptible cells or organisms with the antibody–virus mixture, such as cells in culture, embryonated eggs, or susceptible hosts. The results of the MN assay described here are measured based on cell culture in a microtiter plate format and a color change detected by an automated plate reader. The test is performed with a constant amount of virus and serial dilutions of serum samples to an end point where virus neutralization is no longer detected. The neutralizing antibody titer is thus the reciprocal number of the last dilution of serum with neutralizing activity. The MN assay can be used to detect antibody from pigs with natural exposure or vaccination and can potentially be used to predict cross-protection between strains of influenza A virus.

less

Figures (0) & Videos (0)

Keywords

Techniques:

Cell Fixation, ELISA, 96-well Neutralization Assay, Titration, Cell And Tissue Culture, Vaccination, Cell Culture Maintenance, Data analysis, Virus Neutralization Assay

Models:

Sus scrofa, CM-2 [Human ESC], MDCK

Antibodies:

Anti-mouse

Others:

Serum, Antibody, Microneutralization, Influenza

References

  1. Couch RB (2003) An overview of serum antibody responses to influenza virus antigens. Dev Biol (Basel) 115:25–30
  2. Wharton SA (1987) The role of influenza virus haemagglutinin in membrane fusion. Microbiol Sci 4:119–124
  3. Leuwerke B, Kitikoon P, Evans R et al (2008) Comparison of three serological assays to determine the cross-reactivity of antibodies from eight genetically diverse U.S. swine influenza viruses. J Vet Diagn Invest 20:426–432
  4. Rowe T, Abernathy RA, Hu-Primmer J et al (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37:937–943
  5. Veguilla V, Hancock K, Schiffer J et al (2011) Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 49:2210–2215
  6. WHO (World Health Organization) (2010) Serological diagnosis of influenza by microneutralization assay. . Accessed 2 Aug 2013http://www.who.int/influenza/gisrs_laboratory/2010_12_06_serological_diagnosis_of_influenza_by_microneutralization_assay.pdf
  7. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497

Abstract

The microneutralization (MN) assay is a modification of the serum virus neutralization assay and is a serological test to detect the presence of functional systemic antibodies that prevent infectivity of virus. When infectious virus is mixed with serum antibody, the virus infectivity can be “neutralized” if the antibodies bind to blocking epitopes on the virus. The neutralization effect can be demonstrated by inoculation of susceptible cells or organisms with the antibody–virus mixture, such as cells in culture, embryonated eggs, or susceptible hosts. The results of the MN assay described here are measured based on cell culture in a microtiter plate format and a color change detected by an automated plate reader. The test is performed with a constant amount of virus and serial dilutions of serum samples to an end point where virus neutralization is no longer detected. The neutralizing antibody titer is thus the reciprocal number of the last dilution of serum with neutralizing activity. The MN assay can be used to detect antibody from pigs with natural exposure or vaccination and can potentially be used to predict cross-protection between strains of influenza A virus.

less

References

  1. Couch RB (2003) An overview of serum antibody responses to influenza virus antigens. Dev Biol (Basel) 115:25–30
  2. Wharton SA (1987) The role of influenza virus haemagglutinin in membrane fusion. Microbiol Sci 4:119–124
  3. Leuwerke B, Kitikoon P, Evans R et al (2008) Comparison of three serological assays to determine the cross-reactivity of antibodies from eight genetically diverse U.S. swine influenza viruses. J Vet Diagn Invest 20:426–432
  4. Rowe T, Abernathy RA, Hu-Primmer J et al (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37:937–943
  5. Veguilla V, Hancock K, Schiffer J et al (2011) Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 49:2210–2215
  6. WHO (World Health Organization) (2010) Serological diagnosis of influenza by microneutralization assay. . Accessed 2 Aug 2013http://www.who.int/influenza/gisrs_laboratory/2010_12_06_serological_diagnosis_of_influenza_by_microneutralization_assay.pdf
  7. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497

Figures (0) & Videos (0)

Advertisement

Keywords

Techniques:

Cell Fixation, ELISA, 96-well Neutralization Assay, Titration, Cell And Tissue Culture, Vaccination, Cell Culture Maintenance, Data analysis, Virus Neutralization Assay

Models:

Sus scrofa, CM-2 [Human ESC], MDCK

Antibodies:

Anti-mouse

Others:

Serum, Antibody, Microneutralization, Influenza

microneutralization assay